Evidence map›Paper›PMID 41065834›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Assessing the disease burden of opioid use disorder in western europe: trends, gender differences, and future directions.

Dingwen Xu, Rui Zhang, Jingjing Li, Jijun Wu, Zhe Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dingwen Xu *Department of Clinic, School of Medicine, Yangzhou Polytechnic College, Yangzhou, China.
Rui Zhang *Department of Life Science, University College London, London, UK.
Jingjing LiDepartment of Clinic, School of Medicine, Yangzhou Polytechnic College, Yangzhou, China.
Jijun WuDepartment of Interventional Radiology, Zhongshan Torch Development Zone People's Hospital, Zhongshan, China. xinxienorthwu@yeah.net.
Zhe YangDepartment of Orthopaedics, Shanxi Provincial People's Hospital, Shanxi, China. yangzhe2172656@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioid Use Disorder (OUD) has emerged as a significant public health challenge worldwide, and the issue of OUD in Western Europe is equally severe. However, there is a lack of systematic analyses specifically focusing on OUD in Western Europe, with existing research primarily concentrated in North America. This limitation hampers our understanding of the true burden of OUD in Western Europe. This study aims to fill the gap in research regarding the burden of OUD in Western Europe by analyzing the epidemiological characteristics from 1990 to 2021. It seeks to provide a comprehensive assessment of the disease burden in the region and to offer scientific evidence for policy-making. The study is based on data from the Global Burden of Disease (GBD) 2021, utilizing the publicly available database from the Institute for Health Metrics and Evaluation (IHME). It analyzes indicators such as incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) across Western European countries. The study employs the Estimated Annual Percentage Change (EAPC) to analyze trends and uses the Autoregressive Integrated Moving Average (ARIMA) model to predict the changes in OUD over the next fifteen years. The analysis reveals that the burden of OUD in Western Europe is generally high across all age groups, particularly among those aged 15 to 60. The burden is significantly higher in males than in females, although the rate of increase is faster among females. Between 1990 and 2021, both mortality rates and years lost to disability have increased significantly, with notable growth in the disease burden in certain countries such as Sweden and the United Kingdom. The ARIMA model predicts that the overall burden of OUD in Western Europe will continue to exceed global levels by 2036, with significant variations in trend patterns among individual countries. This study reveals the complex epidemiological characteristics and future trends of OUD in Western Europe, providing important evidence for the development of targeted prevention and intervention strategies. By identifying high-risk populations and key intervention areas, resource allocation can be optimized, enhancing the effectiveness of interventions to effectively address the opioid crisis.

Indexed as

Cost of IllnessOpioid-Related DisordersAdolescentAdultAgedDisability-Adjusted Life YearsEuropeFemaleGlobal Burden of DiseaseHumansIncidenceMaleMiddle AgedPrevalenceSex FactorsYoung AdultASMRGBDOpioid use disorderWestern Europe

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.